Safety, pharmacokinetics, and antimalarial activity of the novel triaminopyrimidine ZY-19489: a first-in-human, randomised, placebo-controlled, double-blind, single ascending dose study, pilot food-effect study, and volunteer infection study.

Bridget E. Barber, Melissa Fernandez, Hardik B. Patel, Catalina Barceló, Harilal Patel, Stacey Llewellyn, Azrin N. Abd‐Rahman, Sunil Sharma, Mukul R. Jain, Ashok Ghoghari, Ilaria Di Resta, Aline Fuchs, Ioanna Deni, Tomas Yeo, Sachel Mok, David A. Fidock, Stephan Chalon, Jörg J. Möhrle, Dhruvanshu Parmar, James McCarthy, Kevinkumar Kansagra